YD Bio Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | +45.8% | +16.9% | |
| – | – | – | – | +80.5% | +80.0% | |
| – | – | – | – | +1.2% | -127.1% | |
| – | – | – | – | – | +226.1% | |
| – | – | – | – | +634.6% | +239.5% | |
| – | +400.4% | +34.9% | -93.0% | +890.4% | +223.4% | |
| – | – | – | – | – | – | |
| – | – | – | – | -64.0% | -100.0% | |
| – | – | -56.5% | -99.5% | -7,955.4% | – | |
| – | – | – | +95.8% | +513.2% | -106.1% | |
| – | – | -56.5% | -99.6% | -10,509.7% | – | |
| – | – | -56.5% | -99.4% | -5,858.2% | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.